Biotricity's Q2 revenue, gross margin improve on technology fee strength
BTCY•Biotricity's fiscal Q2 revenue rose 11.5% year over year to $4.33 million, while gross margin increased to 83.3% from 81.9%. Income from operations rose 23.7%, outpacing a 12.5% increase in operating expenses.




